DeHeng Hong Kong and Beijing Offices Assisted Hong Kong Pharma Digital Technology Holdings Limited in Completing NASDAQ Listing

2025-01-20

Recently, DeHeng’s Hong Kong and Beijing Offices assisted Hong Kong Pharma Digital Technology Holdings Limited in completing its listing on the NASDAQ stock exchange in the United States. On December 20, 2024, the issuer obtained approval from the U.S. Securities and Exchange Commission (SEC) for the effectiveness of its common stock registration and successfully listed on the NASDAQ stock exchange on January 15, 2025, with the stock ticker HKPD. The issuer, a Cayman Islands company, primarily operates cross-border pharmaceutical supply chain services through its Hong Kong subsidiary and is a logistics partner of well-known logistics and internet sales platforms such as Cainiao.

DeHeng’s Hong Kong Office served as the Hong Kong lawyer for the issuer in this project, under the leadership of partner Liu Kuangyao and with primary support from trainee lawyer Liu Junlang. They participated in the relevant Hong Kong legal work throughout the process and provided comprehensive, efficient, and professional legal services for the project.

DeHeng’s Beijing Office acted as the domestic lawyer for the issuer in this project and provided special legal opinions on several domestic Chinese legal issues, under the leadership of partner Zhang Xiaodan and with primary support from lawyer Yu Xinqian.